WO2000040709A2 - PROCEDE PERMETTANT DE FAIRE CODER AUX PLANTES ET CELLULES DE PLANTES DE LA LYSINE OU DE LA METHIONINE OU DU TRYPTOPHANE OU DE LA THREONINE A DES CODONS D'ARNm DIFFERENTS DE CEUX SPECIFIANT NORMALEMENT CES ACIDES AMINES PARTICULIERS DURANT LA SYNTHESE PROTEIQUE - Google Patents
PROCEDE PERMETTANT DE FAIRE CODER AUX PLANTES ET CELLULES DE PLANTES DE LA LYSINE OU DE LA METHIONINE OU DU TRYPTOPHANE OU DE LA THREONINE A DES CODONS D'ARNm DIFFERENTS DE CEUX SPECIFIANT NORMALEMENT CES ACIDES AMINES PARTICULIERS DURANT LA SYNTHESE PROTEIQUE Download PDFInfo
- Publication number
- WO2000040709A2 WO2000040709A2 PCT/IB1999/002125 IB9902125W WO0040709A2 WO 2000040709 A2 WO2000040709 A2 WO 2000040709A2 IB 9902125 W IB9902125 W IB 9902125W WO 0040709 A2 WO0040709 A2 WO 0040709A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- plants
- dna
- plant
- trna
- plant cells
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 74
- 108020004566 Transfer RNA Proteins 0.000 title claims description 178
- 230000015572 biosynthetic process Effects 0.000 title claims description 35
- 238000003786 synthesis reaction Methods 0.000 title claims description 34
- 230000008569 process Effects 0.000 title description 12
- 108020004414 DNA Proteins 0.000 claims abstract description 174
- 210000004027 cell Anatomy 0.000 claims abstract description 164
- 108020004705 Codon Proteins 0.000 claims abstract description 121
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims abstract description 117
- 239000004472 Lysine Substances 0.000 claims abstract description 93
- 238000001243 protein synthesis Methods 0.000 claims abstract description 47
- 230000014616 translation Effects 0.000 claims abstract description 46
- 150000001413 amino acids Chemical class 0.000 claims abstract description 35
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims abstract description 29
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims abstract description 29
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims abstract description 28
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims abstract description 28
- 239000004473 Threonine Substances 0.000 claims abstract description 28
- 229930182817 methionine Natural products 0.000 claims abstract description 28
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims abstract description 25
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims abstract description 22
- 210000001938 protoplast Anatomy 0.000 claims abstract description 18
- 241000196324 Embryophyta Species 0.000 claims description 332
- 108090000623 proteins and genes Proteins 0.000 claims description 120
- 102000004169 proteins and genes Human genes 0.000 claims description 79
- 235000018102 proteins Nutrition 0.000 claims description 76
- 230000000694 effects Effects 0.000 claims description 37
- 235000001014 amino acid Nutrition 0.000 claims description 29
- 229940024606 amino acid Drugs 0.000 claims description 29
- 239000000203 mixture Substances 0.000 claims description 29
- 230000001105 regulatory effect Effects 0.000 claims description 20
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims description 19
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 17
- 240000007594 Oryza sativa Species 0.000 claims description 13
- 102000052866 Amino Acyl-tRNA Synthetases Human genes 0.000 claims description 12
- 108700028939 Amino Acyl-tRNA Synthetases Proteins 0.000 claims description 12
- 230000027455 binding Effects 0.000 claims description 12
- 235000007164 Oryza sativa Nutrition 0.000 claims description 11
- 235000009566 rice Nutrition 0.000 claims description 11
- 239000000411 inducer Substances 0.000 claims description 8
- 230000001172 regenerating effect Effects 0.000 claims description 8
- 239000000126 substance Substances 0.000 claims description 8
- 241000894006 Bacteria Species 0.000 claims description 7
- 108010016634 Seed Storage Proteins Proteins 0.000 claims description 6
- 230000002452 interceptive effect Effects 0.000 claims description 5
- 244000068988 Glycine max Species 0.000 claims description 4
- 241001465754 Metazoa Species 0.000 claims description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims description 3
- 235000010469 Glycine max Nutrition 0.000 claims description 3
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 3
- 241000209140 Triticum Species 0.000 claims description 3
- 235000021307 Triticum Nutrition 0.000 claims description 3
- 229960001230 asparagine Drugs 0.000 claims description 3
- 235000009582 asparagine Nutrition 0.000 claims description 3
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 2
- 239000004475 Arginine Substances 0.000 claims description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 2
- 108010064851 Plant Proteins Proteins 0.000 claims description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 2
- 235000009697 arginine Nutrition 0.000 claims description 2
- 235000013922 glutamic acid Nutrition 0.000 claims description 2
- 239000004220 glutamic acid Substances 0.000 claims description 2
- 235000004554 glutamine Nutrition 0.000 claims description 2
- 235000021118 plant-derived protein Nutrition 0.000 claims description 2
- 229920001184 polypeptide Polymers 0.000 claims description 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 2
- 235000004400 serine Nutrition 0.000 claims description 2
- 102000053602 DNA Human genes 0.000 description 96
- 108060001084 Luciferase Proteins 0.000 description 69
- 239000005089 Luciferase Substances 0.000 description 58
- 230000014509 gene expression Effects 0.000 description 48
- 102000017737 Lysine-tRNA Ligase Human genes 0.000 description 36
- 108010092041 Lysine-tRNA Ligase Proteins 0.000 description 36
- 206010020649 Hyperkeratosis Diseases 0.000 description 32
- 230000009466 transformation Effects 0.000 description 26
- 108091034117 Oligonucleotide Proteins 0.000 description 23
- 108020005029 5' Flanking Region Proteins 0.000 description 21
- 108020005098 Anticodon Proteins 0.000 description 21
- 238000003752 polymerase chain reaction Methods 0.000 description 19
- 108700008625 Reporter Genes Proteins 0.000 description 18
- 241000894007 species Species 0.000 description 16
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 13
- 238000004458 analytical method Methods 0.000 description 13
- 239000002609 medium Substances 0.000 description 13
- 239000013598 vector Substances 0.000 description 13
- 108020005065 3' Flanking Region Proteins 0.000 description 12
- 108020005038 Terminator Codon Proteins 0.000 description 12
- 230000000295 complement effect Effects 0.000 description 12
- 230000001404 mediated effect Effects 0.000 description 12
- 238000010561 standard procedure Methods 0.000 description 11
- 240000008042 Zea mays Species 0.000 description 10
- 238000002741 site-directed mutagenesis Methods 0.000 description 10
- 230000003115 biocidal effect Effects 0.000 description 9
- 241000589158 Agrobacterium Species 0.000 description 8
- 241000588724 Escherichia coli Species 0.000 description 8
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 8
- 238000010276 construction Methods 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 108700020534 tetracycline resistance-encoding transposon repressor Proteins 0.000 description 8
- 108010034634 Repressor Proteins Proteins 0.000 description 7
- 102000009661 Repressor Proteins Human genes 0.000 description 7
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 7
- 235000009973 maize Nutrition 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 230000008929 regeneration Effects 0.000 description 7
- 238000011069 regeneration method Methods 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 108010060309 Glucuronidase Proteins 0.000 description 6
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 6
- 230000012010 growth Effects 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- 239000013612 plasmid Substances 0.000 description 6
- 108091026890 Coding region Proteins 0.000 description 5
- 102000053187 Glucuronidase Human genes 0.000 description 5
- 238000003556 assay Methods 0.000 description 5
- 101150103518 bar gene Proteins 0.000 description 5
- 108010002833 beta-lactamase TEM-1 Proteins 0.000 description 5
- GINJFDRNADDBIN-FXQIFTODSA-N bilanafos Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCP(C)(O)=O GINJFDRNADDBIN-FXQIFTODSA-N 0.000 description 5
- 230000000408 embryogenic effect Effects 0.000 description 5
- 239000012634 fragment Substances 0.000 description 5
- 230000008488 polyadenylation Effects 0.000 description 5
- 230000009261 transgenic effect Effects 0.000 description 5
- 230000001052 transient effect Effects 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- 230000033228 biological regulation Effects 0.000 description 4
- AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 4
- 230000002068 genetic effect Effects 0.000 description 4
- 239000004009 herbicide Substances 0.000 description 4
- 238000009396 hybridization Methods 0.000 description 4
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 4
- 239000002773 nucleotide Substances 0.000 description 4
- 125000003729 nucleotide group Chemical group 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 238000013518 transcription Methods 0.000 description 4
- 230000035897 transcription Effects 0.000 description 4
- ZBMRKNMTMPPMMK-UHFFFAOYSA-N 2-amino-4-[hydroxy(methyl)phosphoryl]butanoic acid;azane Chemical compound [NH4+].CP(O)(=O)CCC(N)C([O-])=O ZBMRKNMTMPPMMK-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 101000640990 Arabidopsis thaliana Tryptophan-tRNA ligase, chloroplastic/mitochondrial Proteins 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- 102000052510 DNA-Binding Proteins Human genes 0.000 description 3
- 101710096438 DNA-binding protein Proteins 0.000 description 3
- 244000000626 Daucus carota Species 0.000 description 3
- 235000002767 Daucus carota Nutrition 0.000 description 3
- 108010025815 Kanamycin Kinase Proteins 0.000 description 3
- FAIXYKHYOGVFKA-UHFFFAOYSA-N Kinetin Natural products N=1C=NC=2N=CNC=2C=1N(C)C1=CC=CO1 FAIXYKHYOGVFKA-UHFFFAOYSA-N 0.000 description 3
- 108010054278 Lac Repressors Proteins 0.000 description 3
- 229930195725 Mannitol Natural products 0.000 description 3
- 102000004587 Methionine-tRNA ligase Human genes 0.000 description 3
- 108010003060 Methionine-tRNA ligase Proteins 0.000 description 3
- 241000208125 Nicotiana Species 0.000 description 3
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 108010029287 Threonine-tRNA ligase Proteins 0.000 description 3
- 102100040537 Threonine-tRNA ligase 1, cytoplasmic Human genes 0.000 description 3
- 102000002501 Tryptophan-tRNA Ligase Human genes 0.000 description 3
- 238000000137 annealing Methods 0.000 description 3
- 238000004113 cell culture Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 230000002363 herbicidal effect Effects 0.000 description 3
- QANMHLXAZMSUEX-UHFFFAOYSA-N kinetin Chemical compound N=1C=NC=2N=CNC=2C=1NCC1=CC=CO1 QANMHLXAZMSUEX-UHFFFAOYSA-N 0.000 description 3
- 229960001669 kinetin Drugs 0.000 description 3
- 239000000594 mannitol Substances 0.000 description 3
- 235000010355 mannitol Nutrition 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 238000002703 mutagenesis Methods 0.000 description 3
- 231100000350 mutagenesis Toxicity 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 238000004114 suspension culture Methods 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- 230000035899 viability Effects 0.000 description 3
- FNQJDLTXOVEEFB-UHFFFAOYSA-N 1,2,3-benzothiadiazole Chemical compound C1=CC=C2SN=NC2=C1 FNQJDLTXOVEEFB-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 239000005964 Acibenzolar-S-methyl Substances 0.000 description 2
- 238000009010 Bradford assay Methods 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- 241000122205 Chamaeleonidae Species 0.000 description 2
- 108010066133 D-octopine dehydrogenase Proteins 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 2
- 108090000331 Firefly luciferases Proteins 0.000 description 2
- 239000005562 Glyphosate Substances 0.000 description 2
- 101150062179 II gene Proteins 0.000 description 2
- 229920003266 Leaf® Polymers 0.000 description 2
- 102000003960 Ligases Human genes 0.000 description 2
- 108090000364 Ligases Proteins 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 241000207746 Nicotiana benthamiana Species 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000002105 Southern blotting Methods 0.000 description 2
- 239000004098 Tetracycline Substances 0.000 description 2
- 230000001133 acceleration Effects 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 230000009089 cytolysis Effects 0.000 description 2
- 238000001378 electrochemiluminescence detection Methods 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- XDDAORKBJWWYJS-UHFFFAOYSA-N glyphosate Chemical compound OC(=O)CNCP(O)(O)=O XDDAORKBJWWYJS-UHFFFAOYSA-N 0.000 description 2
- 229940097068 glyphosate Drugs 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- TWBYWOBDOCUKOW-UHFFFAOYSA-N isonicotinic acid Chemical compound OC(=O)C1=CC=NC=C1 TWBYWOBDOCUKOW-UHFFFAOYSA-N 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 230000031787 nutrient reservoir activity Effects 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 239000011535 reaction buffer Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 229960002180 tetracycline Drugs 0.000 description 2
- 229930101283 tetracycline Natural products 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- 150000003522 tetracyclines Chemical class 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 230000003442 weekly effect Effects 0.000 description 2
- 239000005631 2,4-Dichlorophenoxyacetic acid Substances 0.000 description 1
- 108010020183 3-phosphoshikimate 1-carboxyvinyltransferase Proteins 0.000 description 1
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000219194 Arabidopsis Species 0.000 description 1
- 108050006476 Chlorophyll A-B binding proteins Proteins 0.000 description 1
- ZAQJHHRNXZUBTE-NQXXGFSBSA-N D-ribulose Chemical compound OC[C@@H](O)[C@@H](O)C(=O)CO ZAQJHHRNXZUBTE-NQXXGFSBSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-UHFFFAOYSA-N D-threo-2-Pentulose Natural products OCC(O)C(O)C(=O)CO ZAQJHHRNXZUBTE-UHFFFAOYSA-N 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 108090000204 Dipeptidase 1 Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 206010021033 Hypomenorrhoea Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000209510 Liliopsida Species 0.000 description 1
- OKIZCWYLBDKLSU-UHFFFAOYSA-M N,N,N-Trimethylmethanaminium chloride Chemical compound [Cl-].C[N+](C)(C)C OKIZCWYLBDKLSU-UHFFFAOYSA-M 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
- 238000010222 PCR analysis Methods 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 101710163504 Phaseolin Proteins 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 241000286209 Phasianidae Species 0.000 description 1
- 208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 1
- 206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 108700019146 Transgenes Proteins 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 108090000848 Ubiquitin Proteins 0.000 description 1
- 102000044159 Ubiquitin Human genes 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 229920002494 Zein Polymers 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000000376 autoradiography Methods 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 102000006635 beta-lactamase Human genes 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 210000004534 cecum Anatomy 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003593 chromogenic compound Substances 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000000432 density-gradient centrifugation Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 108010081495 driselase Proteins 0.000 description 1
- 235000005489 dwarf bean Nutrition 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 101150054900 gus gene Proteins 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 108010002685 hygromycin-B kinase Proteins 0.000 description 1
- 238000003119 immunoblot Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000011890 leaf development Effects 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 239000006870 ms-medium Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 108091027963 non-coding RNA Proteins 0.000 description 1
- 102000042567 non-coding RNA Human genes 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 108010082527 phosphinothricin N-acetyltransferase Proteins 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- LFGREXWGYUGZLY-UHFFFAOYSA-N phosphoryl Chemical group [P]=O LFGREXWGYUGZLY-UHFFFAOYSA-N 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- HBMJWWWQQXIZIP-UHFFFAOYSA-N silicon carbide Chemical compound [Si+]#[C-] HBMJWWWQQXIZIP-UHFFFAOYSA-N 0.000 description 1
- 229910010271 silicon carbide Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 101150061166 tetR gene Proteins 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- UZKQTCBAMSWPJD-UQCOIBPSSA-N trans-Zeatin Natural products OCC(/C)=C\CNC1=NC=NC2=C1N=CN2 UZKQTCBAMSWPJD-UQCOIBPSSA-N 0.000 description 1
- UZKQTCBAMSWPJD-FARCUNLSSA-N trans-zeatin Chemical compound OCC(/C)=C/CNC1=NC=NC2=C1N=CN2 UZKQTCBAMSWPJD-FARCUNLSSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940023877 zeatin Drugs 0.000 description 1
- 239000005019 zein Substances 0.000 description 1
- 229940093612 zein Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8251—Amino acid content, e.g. synthetic storage proteins, altering amino acid biosynthesis
- C12N15/8253—Methionine or cysteine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8251—Amino acid content, e.g. synthetic storage proteins, altering amino acid biosynthesis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8251—Amino acid content, e.g. synthetic storage proteins, altering amino acid biosynthesis
- C12N15/8254—Tryptophan or lysine
Definitions
- This invention relates to methods for altering protein synthesis in plant cells and plants so as to modify their properties, including the composition and sequences of proteins synthesized by the plant cells and plants.
- DNA deoxyribonucleic acid
- mRNAs messenger ribonucleic acids
- tRNA transfer RNA
- Amino acids are attached to tRNAs by their cognate aminoacyl tRNA synthetases and are then incorporated into proteins encoded by the mRNAs, such that the sequence of amino acids in proteins is determined by the sequence of mRNA codons corresponding to those amino acids.
- the mRNA codons which normally specify lysine are AAA and AAG; the tRNA lys species which bind these codons have anticodon sequences UUU or CUU, respectively.
- the mRNA codon which normally specifies methionine is AUG; the tRNA met species which binds this codon has anticodon sequence CAU.
- the mRNA codon which normally specifies tryptophan is CCA; the tRNA* 1 ' species which binds this codon has anticodon sequence CCA.
- the mRNA codons which normally specify threonine are ACU, ACC, ACA and ACG; the tRNA d ⁇ r species which bind these codons have anticodon sequences AGU, GGU, UGU or CGU, respectively. These codons are known by persons skilled in the art from the universal genetic code (Table 2). Table 2. Universal Genetic Code
- GTT val v GCT ala A GAT asp D GGT gly G GTC val v GCC ala A GAC asp D GGA gly G GTA val v GCA ala A GAA glu E GGA gly G GTG val v GCG ala GAG glu E GGG gly G
- Plants are the major nutritional source of proteins and amino acids for man and livestock, and proteins produced in plants have industrial and medical value. Modification of the sequences and compositions of these proteins can improve their value. In bacteria, use of altered tRNAs to modify the specificity of coding during protein synthesis has provided a most effective way to study the structure, function and interactions of proteins [Murgola, 1995. In D. Soil and U. RajBhandary (eds), tRNA: Structure, Biosynthesis, and Function, ASM Press, Washington, D.C.].
- altered tRNAs to modify the specificity of coding during protein synthesis in plants can similarly facilitate analysis of the machinery by which proteins are made, will facilitate analysis of protein structure and function, and opens new pathways for the production of proteins having altered amino acid sequences and compositions.
- the predominant seed proteins of cereals and some legumes are deficient in lysine.
- a goal of agricultural science is to develop plant varieties encoding nutritionally balanced proteins.
- One method which has been invented requires changing the DNA sequences encoding the zein seed storage proteins (U.S. Patents 4,885,357 and 4,886,878). The methods disclosed in this invention provides an alternative process to achieve this goal.
- compositions for causing plant cells and plants to code lysine, methionine, tryptophan or threonine at mRNA codons other than those which normally code lysine (AAA, AAG), methionine (AUG), tryptophan (UGG) or threonine (ACU, ACC, ACA, ACG) during protein synthesis.
- DNAs which will express in plant cells and plants, tRNAs that are charged with lysine, methionine, tryptophan or threonine and which pair with mRNA codons other than those normally specifying these amino acids are chemically synthesized or prepared from naturally occurring tRNA genes by mutagenesis.
- DNAs are introduced into plant protoplasts or plant cells or plant tissues, together with DNAs encoding selectable traits such as antibiotic resistance or herbicide resistance, so as to produce stable transformed cell lines or plant tissues in which tRNAs expressed from the DNAs introduce lysine, methionine, tryptophan or threonine at mRNA codons other than those normally specifying these amino acids during protein synthesis.
- Coding of lysine, methionine, tryptophan or threonine at alternative codons during protein synthesis in plant cells and plant tissues may be measured by the simultaneous or subsequent introduction into the plant cells or plant tissues or plants of reporter genes which encode proteins whose function requires coding of lysine, methionine, tryptophan or threonine at codons other than those normally specifying these amino acids.
- the present invention relates to a method for causing plant cells or plant tissue or plants to code lysine or methionine or tryptophan or threonine at mRNA codons other than those normally specifying those particular amino acids during protein synthesis, which comprises: i) Preparing a DNA to express a tRNA which is charged with lysine and which binds to mRNA codons other than AAA or AAG during protein synthesis; or a DNA to express a tRNA which is charged with methionine and which binds to mRNA codons other than AUG; or a DNA to express a tRNA which is charged with tryptophan and which binds to mRNA codons other than UGG; or a DNA to express a tRNA which is charged with threonine and which binds to codons other than ACU, ACC, ACA, ACG, ii) introducing one or more of the said DNAs into plant protoplasts, plant cells or
- Methods are also described to regulate the coding by tRNAs of lysine, methionine, tryptophan or threonine at mRNA codons other than those normally specifying these amino acids temporally or spatially in plant cells or plant tissues or plants.
- Another subject of the invention is a method as above described, and further including the step of regulating the synthesis of the tRNA so as to cause lysine, methionine, tryptophan or threonine coding at codons other than those which normally specify lysine (AAA, AAG), methionine (AUG), tryptophan (UGG) or threonine (ACU, ACC, ACA, ACG) to occur at particular times or in particular tissues.
- Altered coding of lysine, methionine, tryptophan or threonine during protein synthesis can be regulated by controlling the synthesis of the tRNAs from the introduced DNAs or by regulating the charging of the tRNAs by lysyl tRNA synthetase, methionyl tRNA synthetase, tryptophanyl tRNA synthetase or threonyl tRNA synthetase, respectively.
- a binding site for a DNA binding protein is included in the 5' flanking region of the DNA which encodes the tRNA.
- Altering the expression or the binding of the DNA binding protein to the DNA which encodes the tRNA will regulate synthesis of the tRNAs which code lysine, methionine, tryptophan or threonine at mRNA codons other than those normally specifying these amino acids during protein synthesis within the plant cell, plant tissue or plant.
- a DNA encoding a lysyl tRNA synthetase, methionyl tRNA synthetase, tryptophanyl tRNA synthetase or threonyl tRNA synthetase which respectively charges the tRNA which codes lysine, methionine, tryptophan or tlrreonine at mRNA codons other than those normally specifying these amino acids is introduced into the plant cell or plant together with the DNA which expresses the tRNA.
- a further subject of the invention is then a method as above described, wherein said DNA contains a site bound by a protein capable of interfering with the synthesis of the tRNA or wherein the synthesis of the protein which interferes with the synthesis of the tRNA is determined by a promoter whose activity is regulated.
- the binding to said DNA by the protein which interferes with synthesis of the tRNA may be determined by a chemical inducer.
- From the transformed plant cells and plant tissues can be regenerated plants which code lysine, methionine, tryptophan or threonine at codons other than those normally specifying these amino acids during protein synthesis to produce proteins whose amino acid sequences, compositions and properties are altered.
- Another subject of the present invention is a method for producing plant cells or plant tissues or plants in which the utilization of tRNAs during protein synthesis is enhanced which comprises : i) preparing a DNA which will express a functional aminoacyl tRNA synthetase, ii) introducing said DNA into plant protoplasts, plant cells, or plant tissues or plants, iii) selecting the plant cells and plant tissues or plants which stably maintain said DNA, iv) and regenerating, if necessary, plants which stably maintain said DNA.
- the aminoacyl tRNA synthetase charges tRNAs with lysine or with methionine or with tryptophan or with threonine.
- This aminoacyl tRNA synthetase is preferably from a plant, and advantageously contains the sequence SEQ ID n° 1 specified in the sequence listing.
- It may also be from a bacterium, a yeast, or an animal.
- the synthesis of the aminoacyl tRNA synthetase is regulated by promoters which are tissue specific or whose activity is altered by chemical inducers.
- said tRNA is preferably from a plant and may for example be selected from plant tRNA Iys , plant tRNA met , plant tRNA t ⁇ p and plant tRNA thr .
- Said tRNA may also be from a yeast, or from an animal.
- the mRNA codon to which the tRNA binds during protein synthesis specifies polypeptide chain termination.
- the mRNA codon to which the tRNA binds during protein synthesis specifies one of the following amino acids: glutamine, asparagine, arginine, glutamic acid, serine.
- the proteins synthesized by protein synthesis in the plant cells, tissues or plants include seed storage proteins, and non-plant proteins, such as immunoglobulines.
- the plant encompassed by the present invention may preferably be selected from corn, soybeans, wheat, rice, rape and pea.
- the amino acid coded using mRNA codons other than those which normally code it is one amino acid selected from lysine, methionine, tryptophan and threonine. More particularly, the amino acid coded using mRNA codons other than those which normally code it is lysine.
- the process of this invention employs DNAs which express tRNAs that are charged with lysine in plant cells and plants.
- tRNAs include the cytoplasmic tRNA Lys species of plants (one is known at present) and the tRNA Lys species of bacteria (E. coli) which also is charged with lysine by the plant lysyl tRNA synthetase.
- E. coli tRNA Lys species of bacteria
- the invention may employ the tRNA ⁇ g ⁇ of plants, which also is charged with lysine by the plant lysyl tRNA synthetase and which codes lysine at codons other than AAA and AAG.
- the sequences of the DNAs corresponding to these tRNAs are:
- Plant tRNA 1 ⁇ (SEQ ID n° 2) : gcccgtctag ctcagttggt agagcgcaag gctcttaacc ttgtggtcgt gggttcgagc 60
- Plant tR A£e A (SEQ ID n° 3) : ggattcgtgg cgcaatggta gcgcgtctga ctctagatca gaaggttgcg tgttcgattc SO
- E. coli tRNA 1 ⁇ (SEQ ID n° 4) : gggtcgttag ctcagttggt agagcagttg acttttaatc aattggtcgc aggttcggaa 60 tcctgcacga cccacca 77 (The tRNA anticodon sequences are underlined).
- tRNA Lys species from other organisms can also serve because the tRNA sequence elements used by the plant lysyl tRNA synthetase for binding and charging tRNA have been conserved throughout evolution and are present in all known tRNA Lys species.
- the particular lysyl tRNA synthetase which charges a particular tRNA may be expressed together with that tRNA in the plant cell, so as to ensure the tRNA is charged with lysine.
- the method disclosed in this invention permits the facile determination of whether a particular tRNA Lys species will code lysine at codons other than AAA or AAG during protein synthesis in plant cells and plants.
- sequences of tRNA ys species of other organisms and their cognate lysyl tRNA synthetases may be accessed through the EMBO/Gen Bank/DDBJ nucleotide sequence databases and from the compilation of tRNA sequences and sequences of tRNA genes published annually by Nucleic Acids Research (Oxford University Pres, Oxford, U.K.).
- flanking sequences of the DNA encoding a tRNA modulate expression in plant cells of that tRNA (Ulmasov and Folk, 1995. The Plant Cell 7: 1723-1734). Consequently, in the construction of DNAs to stably express tRNAs in plant cells and plants, it is desirable to include flanking sequences which permit efficient tRNA expression.
- flanking sequences which permit efficient tRNA expression.
- the 5' and 3' flanking sequences of the A. thaliana tRNA ys gene sufficient to cause efficient expression of tRNA Lys species in monocot and dicot cells and plants are:
- the 5' and 3' flanking sequences of other plant tRNA genes (the tR A ⁇ , tRNA 1 ⁇ tRNA ⁇ tRNA ⁇ 5 and tRNA Leu genes) which are known to be expressed efficiently are also expected to function. These sequences are available in the EMBO/GenBank/DDBJ Nucleotide Sequence Databases or by reference to the sequences and citations in Ulmasov and Folk, 1995, which are incorporated by reference.
- nucleotides 179-195 in the above 5' flanking sequence, or at a comparable position in the 5' flanking sequences of the other specified tRNA genes a site bound by a DNA binding protein capable of interfering with transcription, as for example the sequence bound by the lac repressor (SEQ ID n° 7): attgtgagcg ctcaat 18 or the sequence bound by the tet repressor (SEQ ID n° 8) : actctatcac tgatagagt 19 Substitution of these sequences at this site has been shown to not impair synthesis of the tRNA in the absence of protein binding.
- Sequences bound by other proteins should also function and variations in these sequences and slight adjustments in the site of substitutions may be used so long as protein binding is sufficient to block expression of the tRNA, and introduction of the binding site for the protein does not impair synthesis of the tRNA in the absence of the protein.
- a convenient method to analyze in transient assays in plant cells the synthesis of tRNAs from such DNA constructs is provided in Ulmasov et al. 1997( Plant Mol. Biol. 35:417-424) and this method is incorporated by reference.
- Binding of proteins such as the lac repressor or the tet repressor to their respective sites introduced into the 5' flanking sequence of tRNA genes expressed in plant cells reduces tRNA expression three to ten fold, and the degree of repression can be controled by regulating either the concentration of the protein in the plant cell or by interfering with its capacity to bind to the 5' flanking sequences by exposing plant cells or plants to inducers such as lactose or tetracycline or their analogs, which bind to the repressors and prevent them from binding to DNA.
- the concentration of the repressors in the cell is determined by their synthesis, which is a function of the promoter used to express the repressor.
- a subsequent section will relate to the types of promoters which should be used to drive the synthesis of the repressor.
- a complete double stranded DNA constructed to express a tRNA in plant cells and plants should include the coding sequence of the desired tRNA bounded by the 5' and 3' flanking sequences specified above. As the size of this DNA approaches 400 bp, it is convenient to assemble it from smaller oligonucleotides (which can be purchased commercially), each having a length of 40-50 nucleotides, with 5' phosphoryl termini.
- the oligonucleotides which make up the sequence of one strand of the DNA should span the 5' and 3' termini of the complementary oligonucleotides which make up the sequence of the other strand of DNA so as to permit the complete DNA to be prepared by annealing and ligating the oligonucleotides together.
- the oligonucleotides at the termini of the DNA may be synthesized so as to include cohesive termini which will facilitate ligation to a vector for cloning in E. coli. This method has been used for the synthesis of numerous genes (see for example, Wosnick et al., 1987. Gene 60:115-127).
- Optimal conditions used for annealing oligonucleotides depend upon the precise sequences and concentrations of the oligonucleotides.
- Pertinent variables include using a buffer at neutral pH, (such as Tris-HCl) including 10-100 mM Na + or K + to neutralize the charges of DNA phosphates and use of equimolar concentrations of each oligonucleotide in the range of one micromolar so as to enable association in a convenient time.
- a buffer at neutral pH such as Tris-HCl
- equimolar concentrations of each oligonucleotide in the range of one micromolar so as to enable association in a convenient time.
- the full length DNA is then introduced into a suitable vector (available from commercial sources) with complementary termini to those present in the DNA, for transformation into E. coli and amplification by standard procedures.
- the DNA should be extracted from the E. coli and purified by buoyant density gradient centrifugation in CsCl or by chromatography on commercially available resins suitable for DNA purification.
- DNA encoding the tRNA together with flanking sequences may be constructed by polymerase chain reaction (PCR).
- PCR polymerase chain reaction
- tRNA ys _it is convenient to use PCR primers complementary to the 5' and 3' flanking sequences and which also include terminal sequences cleaved by a restriction endonuclease.
- the tRNA ⁇ ugene can be isolated from thaliana genomic DNA (EMBO/GenBank DDB5 Accession No.
- Standard conditions for PCR reactions usually include 10 mM Tris HC1, pH 8.0, 50 mM KCl, 1.5 mM MgCl 2 , 0.01% gelatin, 2mM of each dNTP and 0.1% Triton X-100, 20 pmoles of primer and 2.5 ⁇ mls of Taq polymerase in a final volume of 0.1 ml. Temperatures and lengths of cycles depend upon the base composition of the DNA, and general rules of determining such are available in standard laboratory manuals such as Sambrook et al, 1987 and Ausubel et al, 1997.
- PCR products are purified by standard methods, such as adsorption and elution from glass beads, and then ligated into a suitable vector and transformed into E. coli, from which the DNA may be purified by standard methods described in laboratory manuals such as Sambrook et al., 1987 and Ausubel et al., 1997.
- the process of this invention employs expressing, in plant cells and plants, tRNA species whose anticodon sequences pair with mRNA codons other than AAA or AAG.
- tRNA anticodon sequences other than UUU or CUU.
- changing the plant tRNA ys anticodon sequence from UUU to CCU causes the tRNA Lys to pair with the mRNA codon AAG and to code Lys in place of Arg; a change from UUU or CUU to GUU or to AUU causes these tRNA Lys species to pair with the mRNA codons, AAC or AAU, respectively and to code Lys in place of Asn.
- Reference to the genetic code in a standard text provides the full list of possible codons and in turn, the complementary anticodon sequences of the tRNAs which will pair with them.
- mRNA codons AAU, AAC, CAA, CAG, CGU, CGC, CGA, CGG, AGA, AGG, UAG, UAA, UGA. It is the corresponding anticodon sequences in the DNAs which should be used in place of the TTT or CTT anticodon sequences which normally are present in the tRNA Lys gene.
- the desired anticodon sequence can be specified in the DNA encoding the tRNA during its synthesis, either in the sequence of the oligonucleotide used to prepare the DNA, or by site-directed mutagenesis of the DNA following its preparation.
- Site-directed mutagenesis is standard to the art as a number of procedures are clearly described in the literature and in laboratory manuals such as Sambrook et al, 1987 and Ausubel et al, 1997 and kits with all of the reagents are detailed protocols and commercially available.
- the procedure of Nickoloff et al, (Methods in Molecular Biology 58: 455-468, 1996) has been found to be particularly convenient.
- oligonucleotide (of approximately 18-20 nt) complementary to the anticodon stem and loop of the tRNA sequence in the DNA with the desired anticodon sequence positioned near the middle of the oligonucleotide.
- the oligonucleotide can be purchased commercially, and is mixed with the double stranded vector DNA containing the tRNA gene, together with a second oligonucleotide which contains a selectable marker such as a restriction enzyme site.
- the DNAs are denatured and annealed and the oligonucleotides extended by DNA polymerase, and then ligated with DNA polymerase. They are transformed into E.
- DNAs having the desired change in the tRNA gene are identified by DNA sequencing or by hybridization to oligonucleotides having the desired sequence by procedures which are standard to the art and may be found in Sambrook et al, 1987 and Ausubel et al., 1997.
- tRNAs which are not normally charged by the plant lysyl tRNA synthetase may acquire this property when their anticodon sequences are altered. This is the case for the plant tRNA Trp whose anticodon has been changed to CUA by mutagenesis of the DNA which encodes tRNA T ⁇ p using the procedure described above.
- the resulting tRNA 1 ⁇ transiently expressed in plant cells codes lysine at the chain terminating codon UAG during protein synthesis in plant cells (Ulmasov et al., 1998, Nucleic Acids Research 26:5139-5141).
- DNAs encoding this tRNA or any other which is charged by lysyl tRNA synthetase can be employed in plant cells or plants to code lysine at codons other than AAA or AAG in plant cells or plants.
- the process of this invention may employ expressing in plant cells or plants:
- the preparation and use of DNAs expressing these proteins follows:
- Expression of a tRNA in a plant cell can be regulated by a repressor protein which binds to the 5' flanking sequences of the tRNA gene and which interferes with transcription.
- a repressor protein which binds to the 5' flanking sequences of the tRNA gene and which interferes with transcription. This permits coding of lysine at codons other than AAA or AAG to be controlled during the life of the plant cell or plant and to be directed to specific tissues during the development of the plant. This may be useful to prevent possibly deleterious effects of coding of lysine at alternative codons during the synthesis of proteins which are important for the growth of the plant cell or plant.
- the repressor protein should be expressed by a chimeric gene under the control of a promoter whose activity is regulated during development, or in specific tissues, or by chemical or physical inducers which can be applied at will.
- the tissue, developmental stage or time at which it is desired for the tRNA to be expressed so as to code lysine at codons other than AAA or AAG determines the promoter which should be used to drive the transcription of the lac repressor or the tet repressor or other repressor protein.
- useful promoters include (but are not limited to) the CaMV35S promoter (U.S.
- Patent 5352605 and selected sub-elements for tissue specific expression, or the PR-l ⁇ promoter which is activated by foliar sprays of benzothiadiazole (BTH) or isonicotinic acid (Gorlach et al, 1996. Plant Cell 8:629-643) or the dark and light regulated chlorophyll A B Binding Protein Promoter (U.S. Patent 5656496).
- BTH benzothiadiazole
- isonicotinic acid Gorlach et al, 1996. Plant Cell 8:629-643
- the dark and light regulated chlorophyll A B Binding Protein Promoter U.S. Patent 5656496.
- the construction of chimeric genes which express in plant cells and plants, repressors under the control of these plant promoters together with appropriate regulatory sequences such as polyadenylation signals, an intron to determine splicing and a viral translational enhancer is now standard to the art (for example, see U.S.
- the chimeric gene for the expression of the repressor protein may be physically linked to the gene for the expression of the tRNA, or these genes may be present on separate DNA molecules. Additional genes necessary for the expression of antibiotic resistance or other selectable markers used for the introduction, selection and maintenance of DNAs in transformed plant cells and plants should be added to these DNAs, as is standard to the art.
- Appropriate promoters for the expression of the lysyl tRNA synthetase include those specified above, and as well, particularly those which direct expression of plant storage proteins such as the French bean ⁇ phaseolin gene promoter or the maize zein promoters or the rice glutelin promoters, so that the lysyl tRNA synthetase is expressed at the same time and in the same tissues as the genes for the seed storage proteins.
- the specified promoter should be placed in an appropriate position to direct the synthesis of the coding sequences for the lysyl tRNA synthetase which is to be expressed.
- lysyl tRNA synthetase Regulatory elements required for efficient expression in plant cells and plants, such as a polyadenylation signal, an intron to promote splicing and a viral translational enhancer should be included in the DNA encoding the lysyl tRNA synthetase, as is now standard to the art of expressing proteins efficiently in plant cells or plants.
- the DNA for the expression of the lysyl tRNA synthetase may be physically linked to the DNA for the expression of the tRNA, or they may be present in separate molecules. Additional genes, including those expressing antibiotic resistance or other selectable traits used for the introduction, selection and maintenance of the DNAs in transformed plant cells and plants should be added to either DNA as is standard to the art. Expression of the A.
- thaliana lysyl tRNA synthetase in plant cells will enhance utilization of plant tRNAs which code lysine at mRNA codons other than AAA or AAG.
- the amino acid sequence for the A. thaliana lysyl tRNA synthetase is provided in the Sequence Listing as Seq. ID n° 1.
- a lysyl tRNA synthetase of another organism is also expected to function with tRNAs from that organism, when expressed in plant cells. Coding of lysine at mRNA codons other than AAA or AAG may be sensitively detected and measured by the use of reporter genes whose products rely upon coding of lysine at codons other than AAA or AAG for their activity.
- the firefly luciferase and the TEM-1 ⁇ - lactamase enzymes require a lysine in the substrate binding site or catalytic center, respectively, so genes for these enzymes with codons other than AAA or AAG in place of the codon for that critical lysine express proteins with greatly reduced, or undetectable enzymatic activity.
- utilization in protein synthesis of tRNAs which code lysine in place of the AAA or AAG mRNA codons causes the synthesis of functional enzymes whose activity can be sensitively measured in plant cells and plants.
- Measurement of the activity of these "reporter” enzymes is thereby a way to measure coding of lysine at codons other than AAA and AAG during protein synthesis within the plant cell or plant, and should be used to identify the plant cells or plants modified by the process of this invention.
- LUC reporter gene having alternate codons in place of the AAG (Lys) codon 206 which is important for luciferase function is performed by site- directed mutagenesis of the LUC gene at codon 206 by standard procedures.
- TEM-1 ⁇ lactamase reporter having a codon other than AAA (Lys) at position 73 in the consensus numbering system of Ambler et al., (Biochem. J. 276: 269-270, 1991) is performed by site-directed mutagenesis of the TEM-1 ⁇ lactamase gene using standard procedures.
- the TEM-1 ⁇ lactamase coding sequence is made part of a chimeric gene for expression in plant cells using the CaMN35S promoter and a polyadenylation sequence using standard procedures, as is described for the construction of the LUC reporter gene (Ulmasov and Folk, 1995). Expression of luciferase may be measured as described by Ulmasov and Folk, 1995. Expression of ⁇ lactamase in plant cells may be measured with chromogenic substrates as described by Moore et al., 1997, Analytical Biochemistry 247:203- 209.
- the process of this invention requires introducing D ⁇ As encoding tR ⁇ As which code lysine at codons other than AAA or AAG, as described in the previous sections, into plant protoplasts or plant cells or plant tissues together with genes encoding antibiotic resistance or herbicide resistance so the cells taking up the D ⁇ As are selected and the expression of the D ⁇ As stably maintained. Plants may be regenerated from the transformed plant cells or tissues using methods standard to the art.
- D ⁇ As encoding the repressor proteins, a lysyl tR ⁇ A synthetase and the reporter gene(s) may be introduced together with the D ⁇ As encoding the tR ⁇ As so as to regulate tR ⁇ A synthesis and utilization and to measure lysine coding at alternative codons.
- Procedures by which to introduce these D ⁇ As into particular plant cells or plant tissues and to regenerate plants from them are now standard to the art. A few representative procedures are provided below for specific families of plants, but it should be understood that as improvements and new procedures are developed, they may be substituted.
- D ⁇ As prepared as described in the previous sections may need to be modified for introduction into plant cells or tissues by Agrobacterium-mediated transfer.
- Procedures for the construction of Agrobacterium tumefaciens transformation vectors are well known in the art; see, for example, Hajdukiewicz et al., 1994, Plant Mol. Biol. 25:989-994 and McCormac et al., 1997, pBECKS. Molecular Biotechnology 8: 199-213.
- D ⁇ As introduced by physical or chemical means, such as biolistic bombardment or PEG-mediated transformation do not require the specific sequences used by Agrobacterium to transfer D ⁇ A.
- the DNAs encoding the tRNA and any proteins used to regulate or measure coding of Lys at codons other than AAA or AAG should contain or be cotransformed with DNAs containing traits suitable for the selection of transformed cells and transformed tissue that are appropriate for the plant species. Examples include the antibiotic resistance genes neomycin phosphotransferase II and hygromycin phosphotransferase or the phosphinothricin acetyltransferase or EPSP synthase genes conferring resistance to the herbicides basta or glyphosate, respectively. These DNAs should be homogenous and highly purified by CsCl gradient centrifugation or by chromatography through ion exchange or adsorption resins suitable for purifying DNA (available from commercial sources) by procedures standard to the art.
- one appropriate method employs microprojectile bombardment of embryogenic maize suspension cultures with the aforementioned DNAs modified to include antibiotic resistance genes such as the bar gene or the neomycin phosphotransferase II (NPTII) gene having the appropriate regulatory signals to ensure their expression.
- DNAs containing antibiotic resistance genes may be mixed together with the DNAs coding the tRNA and proteins and used to co-transform plant cells or tissues or plants.
- Selectable traits include those encoded by the hygromycin gene, or the NPT II gene or the bar gene under the control of suitable promoters and regulatory sequences, all of which can be obtained from laboratories practicing these methods.
- suitable promoters and regulatory sequences all of which can be obtained from laboratories practicing these methods.
- appropriate procedures now employ microprojectile bombardment or transformation mediated by Agrobacterium vectors with bar or hygromycin or glyphosate resistance genes as selectable markers (Ortiz et al., 1996, Plant Cell Reports 15:159-163; Cheng et al., 1997. Plant Physiol. 115:971-9801
- methods for stable transformation include agrobacterium-mediated introduction of DNA into leaf discs, biolistic bombardment and PEG- mediated transformation of protoplasts, cells and embryogenic callus, all of which are standard to the art.
- a convenient method is transformation by vacuum infiltration of seeds with Agrobacterium vectors (Bechtold et al, 1993 C.R. Acad. Sci., Paris, 316:1194-1199).
- Plant cells or plants into which the DNA which expresses a tRNA that codes lysine at mRNA codons other than AAA or AAG has been introduced together with the selected antibiotic resistance trait should be characterized to ascertain the DNA encoding the tRNA is present and to that lysine coding at mRNA codons other than AAA or AAG occurs.
- specific proteins made in the plant cell or plant which are abundant and easily purified, such as the small subunit of ribulose carboxylase or a seed storage protein may be purified and characterized for their composition and amino acid sequence by standard procedures.
- Specific applications of the process include modification of the amino acid composition of plant storage proteins.
- the alternative codons most likely to be of value will be those which are highly represented in those particular proteins, and these usually include asparagine and glutamine.
- coding of Lys at these mRNA codons will be of value to increase the composition of lysine in these proteins.
- the tRNA genes are most likely to function best when accompanied by the gene for the plant lysyl tRNA synthetase under the control of a seed-specific promoter, so that enhanced utilization of the tRNA occurs during seed storage protein synthesis.
- An alternative application of the process in plant cells or plants is to generate diversity in protein structure in particular proteins which rely upon such diversity for their function. This is the case for the antibodies, which can be expressed in plant cells and plants. Antibodies with greater structural diversity react with more antigens and thereby have utility. Regulation of altered coding by tRNA lys in plant cells or plants into which genes encoding antibodies have been introduced will cause them to be synthesized with lysine at alternative codons. Regulation of such altered coding may be determined by altering the synthesis of the tRNA lys or by regulating the synthesis of a lysyl tRNA synthetase, as described above.
- DNAs . Isolation of A. thaliana tRNA Lys :
- DNA encoding the A thaliana tRNA ys (GenBank accession no. U67679) was isolated from genomic DNA by PCR, utilizing primers specific for the 5' and 3' flanking sequences. The conditions for PCR included 25 cycles of 30s at 94EC, 30s at 55EC and 60s at 72EC with 5' flanking sequence primer: (SEQ ID n 0 9) : gccaaggatg tataagtgtg tcggaact 28 and
- 3' flanking sequence primer (SEQID n° 10) : tccttgggtt tgactaacta acggg 25
- the PCR product was purified by gel electrophoresis and ligated to Srf-1 cleaved PCR-script vector (Stratagene, Inc, La Jolla, CA), yielding ptLys-1.
- the DNA sequence specifying the tRNA ys anticodon was altered by oligonucleotide-directed mutagenesis from CTT to GTT (Asn) or CTC (Glu) by use of the Chameleon Double-Stranded
- LUC reporter genes which detect Lys coding at AAC or GAG codons:
- LUC firefly luciferase
- HindlJJ to BamHJ fragments from these plasmids were subcloned into the Hind III-BamHI site of the pPZP211 plasmid (Hajdukiewicz et al., 1994) to generate the pLUC/Lys ' -(wt), pLUC/Asn 1 -206 and pLUC/Glu reporter D ⁇ As, respectively.
- Nicotiana benthamiana cell suspension cultures were maintained at 25E C with weekly subculture in MS-1 medium composed of Murashige and Skoog salts, Gamborg vitamins, 1 mg/1 2,4-dichlorophenozyacetic acid (2,4-D) and 3% sucrose at pH5.8. Cells were incubated on plates with MS-1 medium plus 0.25 M mannitol and 0.25 M sorbitol (MS-ms medium) for 4 hours. Prior to bombardment, the plasmid D ⁇ As were precipitated onto 1 ⁇ m gold particles and sonicated lightly to completely suspend the particles.
- Southern Blots also confirmed the presence in the plant cells of the D ⁇ As containing the tR ⁇ A genes and the LUC genes in the plant cells.
- Genomic D ⁇ As from individual callus lines were digested with Hind III and electrophoresed through 0.8% agarose gels. D ⁇ A fragments were transferred to nylon membranes by capillary action and UN cross- linked. Prehybridization and hybridization were performed by standard methods as described in Sambrook et al., 1987 and Ausubel et al. 1997. Probes were prepared with the Multiprime D ⁇ A labeling system (Amersham Life Science), using as template a BamH I-Sacl 1.8 Kb restriction fragment of Uid-1 ( ⁇ glucuronidase) coding sequence. (Jefferson et al., 1987 EMBO J. 6:3901-3907). These data indicate the D ⁇ As encoding the tR ⁇ A lys gene is stably maintained by the plant cells.
- calli containing the pLUC/Asnl-206 reporter gene together with the ptLys/Asnl DNA containing the tRNA ⁇ , gene exhibited a median luciferase activity of 34% of the wild type, or approximately sevenfold greater than that of calli transformed with pLUC/Asnl -206 alone (Table 1), indicating that the tRNA ⁇ uu expressed by ptLys/Asnl DNA causes coding of Lys at AAC codons during protein synthesis, restoring luciferase activity. The efficiency of such coding is approximately 30%.
- Calli containing the pLUC/Glu-206 reporter gene expressed 0.7% the median luciferase activity, respectively, of calli containing pLUC/Lys (wt) DNA, because of the presence of Glu at residue 206 in place of the critical lysine (Table 1). This level of luciferase activity is in agreement with that observed with this LUC gene in bacteria and in plant cell transient assays (Chen et al., 1998).
- Coding of lysine at GUU or CUC codons did not affect the viability or growth of the plant cells.
- the efficiency of transformation of the calli with DNAs containing the ptLys/Asn and ptLys/Glu DNAs was not significantly different than the efficiency of transformation of calli with DNAs lacking the tRNA sequences, indicating that expression of the tRNAs which code lysine at alternative codons does not impair the viability of cells.
- DNA encoding the A. thaliana tRNA Lys was isolated from genomic A. thaliana
- Rice (oryzae sativa L, cv Taipei 309) callus was initiated from developing embryos, subcultured weekly in a phytagel-solidified Ms-1 medium composed of Murashige and Skoog salts, Gamborg vitamins, 2 mg/1 2-4D and 3% sucrose at pH 5.8 and maintained at 28E in the dark. Rice callus was incubated in MS-1 medium plus 0.25 M mannitol and 0.25 M sorbitol for 4 hours prior to biolistic bombardment. The D ⁇ A containing the reporter was mixed with the D ⁇ A containing the tR ⁇ A gene in a 2:1 ratio and precipitated onto gold particles as described by Sanford et al., 1993. The particles were lightly sonicated and then the callus was bombarded twice using a Biolistics acceleration device (PDS-1000/lte, BioRad).
- PDS-1000/lte, BioRad Biolistics acceleration device
- callus was moved to Ms-1 medium for three to seven days and then subjected to selection with 1 mg/1 bialaphos for two weeks, followed by subculturing biweekly on Ms-1 medium with 3 mg/1 bialaphos (Ms-3b).
- Bialaphos resistant, transformed callus was isolated seven to nine weeks post-bombardment and maintained as individual callus lines on Ms-3b medium. Regeneration of transformed plants was initiated by placing the transformed callus on 1% phytagel-solidified Ms-1 medium with 5 mg/1 of kinetin for 3 days.
- the slightly desiccated callus was placed in a lighted growth room and grown on Ms-1 medium containing 0.2% phytagel, 1 mg/1 of bialaphos and 5 mg/1 of kinetin or zeatin for an additional 20 days. Regenerated plantlets/shoots were transferred to the Ms-1 medium without hormones and once the plants grew strong roots, they were transferred to artificial soil and grown to maturity at 28EC/22EC day /night and 10-hour light periods.
- PCR was carried out with primers complementary to the 3' and 5' flanking sequences of the tRNA gene, and with primers to the Ubi promoter and LUC coding sequence, respectively.
- the PCR conditions included 30 cycles of 94EC for 1 min, 60EC for 2 min. 72EC for 2 min.
- the PCR products were blotted onto nylon filters and hybridized with ⁇ - 32 P- dATP-labeled oligonucleotide probe complementary to the sequences and the wild type or mutated LUC genes or to the anticodon of the tRNA gene (Ausubel et al., 1997).
- Hybridization was carried out at 50EC in a SSPE solution (Sambrook et al, 1987).
- the filters were washed at 65EC to 75EC for 20 min in 0.5M tetramethylammonium chloride buffered with Tris-HCl, 50mM, pH 8.0 and .002M EDTA with 0.1% SDS at 59C, and the patterns were visualized by autoradiography.
- the bar resistant callus transformed with the 3 different DNA preparations (LUCwt, LUC/am and LUC/am plus ptLys-am/Gus) were tested for lysine coding at the UAG codon by measuring luciferase activity from the Luc/am reporter gene.
- Samples from 43 independent callus lines were examined.
- Callus with the Luc/am-206 gene alone exhibited 0.04% of the luciferase activity of callus with the LUCwt DNA, while callus containing the LUC/am-206 DNA together with the ptLys-am/Gus DNA encoding tRNA L c y u A exhibited 11% of the wild type luciferase activity, on average a 250 fold increase.
- Transformants containing the LUCwt DNA exhibited proteins that reacted with the LUC antibody which ranged from 0.3% to 2% of the total soluble protein, compared with standard luciferase protein.
- the transformed callus and plants containing the LUC/am DNA exhibited no proteins which reacted with antibody directed against luciferase.
- Transformants containing both the LUC/am and pt Lys-am/GUS DNAs exhibited approximately 0.1% of total soluble protein that reacted with the antibody directed against luciferase ptLys-am/GUS.
- PCR products were generated with primers complementary to either tRNA flanking sequences or the Ubi promoter and to luciferase sequences from transformed callus lines and plants. The PCR products hybridized with radiolabeled oligonucleotides specific for the sequences of wild type and mutant LUC and the tRNA gene.
- PCR products from callus lines and plants containing LUC/am and tRNAam constructs showed clear bands of hybridization when probed with oligonucleotides complementary to the region of the LUC and DNA with the chain termination codon, and the anticodon region in ptRNAam, but no hybridizing bands were detected when probed with the oligonucleotide coding wild type sequence.
- LUC/am and ptLys-am/GUS constructs maintained their original mutated codons after integration into the rice genomes of the transformed callus and plants and therefore the luciferase activity detected in these transformants is due to expression of the tRNA ys species which causes coding of lysine at the UAG chain termination codon in LUC/am and restores luciferase activity and protein.
- DNAs expressing tRNA L g s UA which encode the A. thaliana lysyl tRN synthetase and luciferase and the tet repressor.
- DNA encoding the A. thaliana tRNA Lys was isolated and mutagenized to encode tRNA L s UA as described in the previous sections.
- tet 0 1 operator sequence SEQ ID n° 16
- actctatcac tgatagagt 19 by ligation of a double stranded oligonucleotide of which one strand has this sequence.
- DNA encoding the A. thaliana tRNA A was prepared as described previously by site-directed mutagenesis of a plasmid encoding A. thaliana tRNA T ⁇ . (Ulmasov and Folk,
- DNA encoding the A. thaliana lysyl tRNA synthetase was isolated by identifying sequences in the EMBL/GenBank/DDBJ database with homology to the S. cerevisae lysyl tRNA synthetase. These sequences were used to prepare PCR primers with which to isolate the coding sequence the A. thaliana lysyl tRNA synthetase from an A. thaliana cDNA library (Sequence ID No:001). This gene, when expressed in E. coli, produces an active lysyl tRNA synthetase which charges A. thaliana tRNA Lys .in vitro. It was placed under the control of the CaMV35S promoter and upstream of the octopine synthase polyadenylation signal for expression in plant cells.
- Sequences encoding the Luc/am-206 reporter gene which requires Lys coding at UAG codon and sequences encoding the tetR repressor were placed downstream of the CaMN35S promoter and upstream of the octopine synthase polyadenylation signal for expression in plant cells as described in Chen et al., 1998 and Ulmasov et al, 1997.
- Carrot (Daucus carota) protoplasts were prepared from carrot cells grown under ambient light and temperature in a medium containing 4.3 gn/L Murashige and Skoog salts,
- Protoplasts were pelleted and washed with a solution containing 154 mM NaCl, 5 mM KCl, 125 mM CaCl 2 and 5 mM glucose, pH 6.0 and stored for 0.5 to 4 hours at 5NC. Immediately prior to transformation, the protoplasts were sedimented and resuspended in a solution containing 5mM MES, 20 mM CaCl 2 , 0.5M Mannitol, pH 5.7. Plasmid DNA was mixed with 10 6 protoplasts in 0.3 ml and 0.3 ml of 40% solution of polyethylene glycol (PEG) was added and incubated for 5 min at room temperature. Samples were diluted with hormone-free growth medium and incubated for 24-48 hours at room temperature prior to analysis.
- PEG polyethylene glycol
- This result was obtained in six independent experiments, indicating that charging and subsequent utilization of the tRNA L cu A is modulated by expression of high levels of lysyl tRNA synthetase. The most likely explanation for this is that the tRNA lys is not fully charged by lysine within the cell, and expression of high levels of lysyl tRNA synthetase increases charging and concomitant utilization during protein synthesis.
- a tRNA T c P UA which, as a result of changing of its anticodon from CGG to CUA is charged by purified A. thaliana lysyl tRNA synthetase.
- Expression of tRNA ⁇ A in plant cells causes lysine coding at UAG chain terminating codons, as evidenced by the restoration of luciferase activity encoded by LUCam-206 by DNA encoding tRNA T ⁇ jA . Utilization of tRNA ⁇ to code lysine at UAG codons was increased significantly by expression of the gene for A. thaliana lysyl tRNA synthetase, as with tRNA 1 ⁇ ,. These observations indicate that it is possible to regulate coding of lysine at alternative codons by expressing A. thaliana lysyl tRNA synthetase.
- Type I callus as a bombardment target for generating fertile transgenic maize (Zea mays L.). Planta 196: 7-14. Wilde, R.J., Shufflebottom, D., Cooke, S., Jasinska, I., Merryweather, A., Beri, R., Brammar, W.J., Bevan, M., and Schuch, W. 1992. Control of gene expression in tobacco cells using a bacterial operator-repressor system. EMBO J. 11_: 1251-1259.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Plant Pathology (AREA)
- Nutrition Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU41354/00A AU4135400A (en) | 1998-12-24 | 1999-12-24 | Process for causing plant cells and plants to code lysine or methionine or tryptophan or threonine at mrna codons other than those normally specifying these particular amino acids during protein synthesis |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22037598A | 1998-12-24 | 1998-12-24 | |
US09/220,375 | 1998-12-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000040709A2 true WO2000040709A2 (fr) | 2000-07-13 |
WO2000040709A3 WO2000040709A3 (fr) | 2000-11-16 |
Family
ID=22823308
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB1999/002125 WO2000040709A2 (fr) | 1998-12-24 | 1999-12-24 | PROCEDE PERMETTANT DE FAIRE CODER AUX PLANTES ET CELLULES DE PLANTES DE LA LYSINE OU DE LA METHIONINE OU DU TRYPTOPHANE OU DE LA THREONINE A DES CODONS D'ARNm DIFFERENTS DE CEUX SPECIFIANT NORMALEMENT CES ACIDES AMINES PARTICULIERS DURANT LA SYNTHESE PROTEIQUE |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU4135400A (fr) |
WO (1) | WO2000040709A2 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018092072A1 (fr) * | 2016-11-16 | 2018-05-24 | Cellectis | Méthodes de modification de la teneur en acides aminés de plantes par décalages du cadre de lecture |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0823480A1 (fr) * | 1996-08-06 | 1998-02-11 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Expression contrÔlée de gènes en plantes |
-
1999
- 1999-12-24 WO PCT/IB1999/002125 patent/WO2000040709A2/fr active Application Filing
- 1999-12-24 AU AU41354/00A patent/AU4135400A/en not_active Abandoned
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018092072A1 (fr) * | 2016-11-16 | 2018-05-24 | Cellectis | Méthodes de modification de la teneur en acides aminés de plantes par décalages du cadre de lecture |
US11312972B2 (en) | 2016-11-16 | 2022-04-26 | Cellectis | Methods for altering amino acid content in plants through frameshift mutations |
Also Published As
Publication number | Publication date |
---|---|
WO2000040709A3 (fr) | 2000-11-16 |
AU4135400A (en) | 2000-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU701239B2 (en) | Acetohydroxyacid synthase promoter for expression of introduced genes in plants | |
US6563025B1 (en) | Nucleotide sequences encoding anthranilate synthase | |
JPH06505387A (ja) | 高硫黄種子タンパク質遺伝子及び植物中の含硫アミノ酸含有量の増加法 | |
WO1999005902A1 (fr) | Plantes transgeniques resistantes aux agressions dues a la salinite | |
US6096947A (en) | Methods for improving transformation efficiency | |
AU759068B2 (en) | Methods and compositions for producing plants and microorganisms that express feedback insensitive threonine dehydratase/deaminase | |
AU774004B2 (en) | Plant selectable marker and plant transformation method | |
US20030194809A1 (en) | Method of controlling site-specific recombination | |
Boetti et al. | Efficiency of physical (light) or chemical (ABA, tetracycline, CuSO4 or 2‐CBSU)‐stimulus‐dependent gus gene expression in tobacco cell suspensions | |
KR100917574B1 (ko) | 톡소플라빈 분해 효소를 선별 마커로 이용한 형질전환 감자식물체 제조 | |
Jelenska et al. | Streptothricin resistance as a novel selectable marker for transgenic plant cells | |
US7897841B2 (en) | Seed-preferred regulatory elements | |
US20060130184A1 (en) | Seed-preferred regulatory elements | |
US7276596B2 (en) | Promoter from maize invertase inhibitor gene | |
US5474929A (en) | Selectable/reporter gene for use during genetic engineering of plants and plant cells | |
Potrykus et al. | Genetic engineering of crop plants | |
WO1999053069A2 (fr) | Proteines de regulation du cycle cellulaire | |
WO2000040709A2 (fr) | PROCEDE PERMETTANT DE FAIRE CODER AUX PLANTES ET CELLULES DE PLANTES DE LA LYSINE OU DE LA METHIONINE OU DU TRYPTOPHANE OU DE LA THREONINE A DES CODONS D'ARNm DIFFERENTS DE CEUX SPECIFIANT NORMALEMENT CES ACIDES AMINES PARTICULIERS DURANT LA SYNTHESE PROTEIQUE | |
US6770800B2 (en) | Methods of using viral replicase polynucleotides and polypeptides | |
Guerineau | Tools for expressing foreign genes in plants | |
EP1432808B1 (fr) | Regulation de la translation de genes a expression heterologue | |
Madgwick et al. | Genetic Manipulation of Rubisco: Chromatium vinosum rbcL is expressed in Nicotiana tabacum but does not form a functional protein | |
KR101847974B1 (ko) | 단자엽 식물 형질전환을 위한 벼 Os09g0553100 유전자 유래의 항시 발현용 프로모터 및 이의 용도 | |
OĞRAŞ et al. | Expression and inheritance of GUS gene in transgenic tobacco plants | |
WO2000012713A1 (fr) | Sequence promoteur de plantes et ses utilisations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase |